Racial Differences inBRAF/KRASMutation Rates and Survival in Stage III Colon Cancer Patients

Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes

(2015) Frank A. Sinicrope et al.   GASTROENTEROLOGY

Racial/Ethnic Patterns of Uptake of Colorectal Screening, National Health Interview Survey 2000-2008

(2015) Vickie L. Shavers et al.   JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION

Epidemiology of Goblet Cell and Microvesicular Hyperplastic Polyps

(2014) Taha M Qazi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer

(2014) Rona Yaeger et al.   CANCER

B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells

(2014) R. Herr et al.   CANCER RESEARCH

KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)

(2014) H. H. Yoon et al.   CLINICAL CANCER RESEARCH

Excess of Proximal Microsatellite-Stable Colorectal Cancer in African Americans from a Multiethnic Study

(2014) R. M. Xicola et al.   CLINICAL CANCER RESEARCH

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147

(2014) Wilson I. Gonsalves et al.   JNCI-Journal of the National Cancer Institute

The Increasing Incidence of Young-Onset Colorectal Cancer: A Call to Action

(2014) Dennis J. Ahnen et al.   MAYO CLINIC PROCEEDINGS

Associations of Anthropometric Factors with KRAS and BRAF Mutation Status of Primary Colorectal Cancer in Men and Women: A Cohort Study

(2014) Jenny Brändstedt et al.   PLoS One

Interaction Between Age and Race Alters Predicted Survival in Colorectal Cancer

(2013) Uma R. Phatak et al.   ANNALS OF SURGICAL ONCOLOGY

Racial disparities in advanced-stage colorectal cancer survival

(2013) Kristin Wallace et al.   CANCER CAUSES & CONTROL

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

(2013) Frank A. Sinicrope et al.   JOURNAL OF CLINICAL ONCOLOGY

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

(2012) P. G. Gavin et al.   CLINICAL CANCER RESEARCH

Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer

(2012) Daniel J. Sargent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identification of a Poor-PrognosisBRAF-Mutant–Like Population of Patients With Colon Cancer

(2012) Vlad Popovici et al.   JOURNAL OF CLINICAL ONCOLOGY

Contribution of Behavioral Risk Factors and Obesity to Socioeconomic Differences in Colorectal Cancer Incidence

(2012) C. A. Doubeni et al.   JNCI-Journal of the National Cancer Institute

Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution

(2011) B. E. Sylvester et al.   CLINICAL CANCER RESEARCH

Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803

(2011) S. Ogino et al.   CLINICAL CANCER RESEARCH

Racial Disparities in Stage-Specific Colorectal Cancer Mortality Rates From 1985 to 2008

(2011) Anthony S. Robbins et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant Trials

(2011) G. Yothers et al.   JNCI-Journal of the National Cancer Institute

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

(2010) A. Fariña-Sarasqueta et al.   ANNALS OF ONCOLOGY

Role of the Serrated Pathway in Colorectal Cancer Pathogenesis

(2010) Barbara Leggett et al.   GASTROENTEROLOGY

Cigarette Smoking and Colorectal Cancer Risk by Molecularly Defined Subtypes

(2010) David Limsui et al.   JNCI-Journal of the National Cancer Institute

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer

(2010) Wendy De Roock et al.   LANCET ONCOLOGY

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

(2009) Brenda K. Edwards et al.   CANCER

International Trends in Colorectal Cancer Incidence Rates

(2009) M. M. Center et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Alarming Colorectal Cancer Incidence Trends: A Case for Early Detection and Prevention

(2009) A. Umar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The Association of Lifestyle and Dietary Factors with the Risk for Serrated Polyps of the Colorectum

(2009) K. Wallace et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans

(2009) K. Kumar et al.   CLINICAL CANCER RESEARCH

Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial

(2009) Hanna K. Sanoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon Cancer

(2009) Tara M. Breslin et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study

(2008) Hassan Brim et al.   Molecular Cancer